Answers below - however our system is looking at both as opportunities.
From: nyschp.dop-bounce@xxxxxxxxxxxxx [mailto:nyschp.dop-bounce@xxxxxxxxxxxxx] ;
On Behalf Of Tibi-Scherl, Leila
Sent: Monday, June 20, 2016 10:48 AM
To: 'nyschp.dop@xxxxxxxxxxxxx'
Subject: [nyschp.dop] GP2B3A inhibitors & Stress Test Agents
Good morning, all,
A member hospital would like feedback on your practices with GP2B3A inhibitors
and Stress Test Agents. Please respond YES or NO to the following two short
questions:
Is your hospital using to Aggrastat as the primary glycoprotein 2b/3a inhibitor
(as compared to Integrilin)? no
Is your hospital using Lexiscan as the primary nuclear stress test agent? yes
Your time is greatly appreciated. Thank you in advance for taking the time to
respond!
Sincerely,
Leila
--
Leila M. Tibi-Scherl, Pharm.D.
VP, Pharmacy Practice
GNYHA Services, Inc. | 555 W. 57th Street, Suite 1156 | New York, NY 10019
* 212.259.0775 |È646.483.3333 |7 212.541.9032 |*
tibi@xxxxxxxxx<mailto:tibi@xxxxxxxxx>
www.pharmacy.gnyhaservices.com<http://www.pharmacy.gnyhaservices.com/>
PQ Please consider the environment before printing this email.
Confidentiality Notice:
This e-mail message, including any attachments, is for the sole use of the
intended recipient(s) and may contain confidential and privileged information.
Any unauthorized review, use, disclosure or distribution is prohibited. If you
are not the intended recipient, please contact the sender by reply e-mail and
destroy all copies of the original message.
